Clinical Trials on Meningococcal Immunisation

Total 511 results

Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Meningococcal Immunisation

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Recruiting

Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers

Healthy Volunteers | Meningococcal Immunisation

Czechia, Denmark, Finland, Germany, Poland, Romania
The Ottawa Hospital

Completed

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform

Mobile Apps | Immunization | Adverse Event Following Immunisation

Canada
Sanofi

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Meningococcal Immunisation (Healthy Volunteers)

Japan
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (MEQ00064)

Healthy Volunteers | Meningococcal Immunisation

South Africa, India
Sanofi Pasteur, a Sanofi Company

Completed

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Healthy Volunteers | Meningococcal Immunisation

Spain, Hungary, Italy, Singapore
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers

Meningococcal Immunisation (Healthy Volunteers)

Spain, Finland, Germany, Hungary
Sanofi Pasteur, a Sanofi Company

Completed

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Meningococcal Immunisation (Healthy Volunteers)

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Meningococcal Immunisation (Healthy Volunteers)

Denmark, Finland, Germany
Sanofi Pasteur, a Sanofi Company

Completed

A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Meningococcal Immunization
Novartis Vaccines
GlaxoSmithKline

Completed

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Meningococcal Meningitis | Meningoccocal Disease

Hungary, Spain
Epicentre
University of Oslo; Norwegian Institute of Public Health; Medecins Sans Frontieres...

Completed

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Infections, Meningococcal | Meningitis, Meningococcic

Norway, Uganda
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
University of Alabama at Birmingham

Completed

Low Cost Interventions to Improve Adherence to Childhood Immunization Schedule

Childhood Immunization Completion | Childhood Immunization Dropout | Immunization Card | Center Based Education

Pakistan
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Polio Immunisation | Haemophilus Influenzae Type B Immunisation | Rotavirus Immunisation

Thailand
Sanofi

Completed

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Pneumoccocal Immunisation

United States
Prof. Elizabeth Miller
Novartis Vaccines

Completed

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults (MenOccy)

Meningococcal Meningitis, Serogroup A | Meningococcal Meningitis, Serogroup B | Meningococcal Meningitis, Serogroup C | Meningococcal Meningitis, Serogroup Y | Meningococcal Meningitis, Serogroup W

United Kingdom
Chiron Corporation

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis

United Kingdom
Duke University
University of South Carolina; Fogarty International Center of the National... and other collaborators

Completed

mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (MINT)

Immunization

Tanzania
CAMC Health System

Completed

Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study

Immunization

United States
Auburn University
Agency for Healthcare Research and Quality (AHRQ)

Completed

Assessing Barriers and Increasing Use of Immunization Registries in Pharmacies

Immunization

United States
Lifespan Healthcare Resource Limited

Unknown

Immunization Schedule Alert Platform (ISAP)

Immunization

Nigeria
Children's Hospital of Philadelphia
Thrasher Research Fund

Completed

PRIMM Trial (Phone Reminder for IMMunization)

Immunization

Nigeria
Florida State University

Completed

Music Therapy as Procedural Support for Young Children Undergoing Immunizations

Immunization

United States
Sanofi Pasteur, a Sanofi Company

Recruiting

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PEARL)

RSV Immunisation

United States, Argentina, Honduras
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Meningococcal
Geisinger Clinic

Completed

Email-based Reminders Promoting Recommended Pediatric Preventative Visits

Immunization Programs

United States
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Completed

The STOP-HPV Trial 2: Performance Feedback Intervention (STOP-HPV)

Vaccination | Immunization

United States
Public Health England
Imperial College London; Institute of Child Health

Withdrawn

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants (PINC)

Vaccination | Immunization

United Kingdom
University of Minnesota
Merck Sharp & Dohme LLC; University of Kentucky

Completed

Improving Adolescent Vaccination in Appalachian Kentucky (INSPIRE)

Adolescent Immunization

United States
University of Oxford
Imperial College London; University College, London; St George's, University... and other collaborators

Completed

Group B Streptococcus: Attitudes to Immunisation in Pregnancy

Group B Streptococcus | Immunisation During Pregnancy

United Kingdom
Indonesia University

Completed

Immunisation Simulation Using the Real-size Infant Manikin in Medical Education

Immunization Skills

Indonesia
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Unknown

The STOP-HPV Trial 4: Bundle Intervention (STOP-HPV)

Vaccination | Immunization

United States
Assiut University

Unknown

Factor Affecting Childhood Immunization Among Childern.

Child Immunization
Swiss Tropical & Public Health Institute
Innovations for Poverty Action

Completed

Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas (GEVaP)

Immunization Coverage

Ghana
Statens Serum Institut
Bill and Melinda Gates Foundation; Larix A/S; CCBR Clinical Research

Completed

3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Adolescents

Immunization, Booster

Denmark
University of Colorado, Denver
Centers for Disease Control and Prevention

Completed

Adolescent Vaccination in the Medical Home: Established and Innovative Strategies

Immunization Rate

United States
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Withdrawn

The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle (STOP-HPV)

Vaccination | Immunization

United States
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Active, not recruiting

The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle (STOP_HPV)

Vaccination | Immunization

United States
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Active, not recruiting

The STOP-HPV Trial 3: Prompts Intervention (STOP-HPV)

Vaccination | Immunization

United States
University of California, Los Angeles
National Cancer Institute (NCI); Children's Hospital of Philadelphia; University... and other collaborators

Completed

The STOP-HPV Trial 1: Communication Intervention (STOP-HPV)

Vaccination | Immunization

United States
University of Colorado, Denver
Agency for Healthcare Research and Quality (AHRQ)

Completed

Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children

Immunization Rates

United States
PATH

Completed

Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults

Meningococcal Vaccines

United States
University of Florida

Completed

MenB Vaccine: Implementation Via Information, Empowerment and Accessibility (MenBVaccine)

Meningococcal Vaccine

United States
International Centre for Diarrhoeal Disease Research...
Incepta Vaccine Limited

Completed

Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.

Meningococcal Vaccine

Bangladesh
Pfizer

Completed

A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Meningococcal Vaccine

United States, Canada, Finland, Italy, Poland, United Kingdom, Czech Republic, Germany
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Direct Consulting and Logistics

Completed

Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS) (IRISS)

Low Immunization Uptake

Nigeria
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis | Invasive Meningococcal Disease

United States
Pfizer

Completed

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Meningococcal Vaccine

Finland, Spain, Poland
Pfizer

Completed

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Meningococcal Vaccine

United States

Clinical Trials on Meningococcal Immunisation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations